retatrutide lancet (Triple-Action Jab): Phase III trial results published in The reveal that this triple-hormone receptor agonist (targeting GLP-1, GIP, and glucagon receptors) achieves unprecedented Retatrutide (GLP-3) – Y&P Labs
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23






















